Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KORE POTASH PLC Share Issue/Capital Change 2019

Feb 14, 2019

7751_rns_2019-02-14_0f99a241-f274-438d-8ded-d30267c4b81c.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9955P

Kore Potash PLC

14 February 2019

14 February 2019

Kore Potash Plc

("Kore Potash" or the "Company")

Issue of Equity following Conversion of Employee Performance Rights

Kore Potash plc announces that it has today, 14 February 2019, issued 1,886,996 new Ordinary shares of a nominal value of USD$0.001 each via the conversion of 1,886,996 Class C Employee Performance Rights into fully paid Ordinary shares. Application has been made for these shares to be admitted to trading on AIM on 19 February 2019. These shares rank pari passu with the existing Ordinary shares in issue.

Following this issue, the Company's issued share capital consists of 862,739,689 shares. No shares are held in treasury. Accordingly, the total number of voting rights in the Company is 862,739,689.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

ENDS

For further information, please visit www.korepotash.com or contact:

Kore Potash

Brad Sampson - CEO
Tel: +27 11 469 9140
Tavistock Communications

Jos Simson

Edward Lee
Tel: +44 (0) 20 7920 3150
Canaccord Genuity - Nomad and Broker

Martin Davison

James Asensio
Tel: +44 (0) 20 7523 4600

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IOEUSVNRKUAUARR